Omnimmune Holdings Stock Forecast for 2023 - 2025 - 2030
Updated on 05/16/2024
Stock Rating
0
Price Target
$0.00
Consensus
-
Upside
0.00%
Analysts
0
Stock Rating
0
Upside
0.00%
Analysts
0
Price Target
$0.00
Omnimmune Holdings Stock Forecast and Price Target
Year-long price target forecasts from prominent analysts have recently been released for Omnimmune Holdings, with an average price target of $0.00. This potential gain of 100 percent from the previous closing price in August, 2023 is calculated on a high forecast of $0.00 and a low estimate of $0.00. If you're interested in investing in this company, why not also look at its competitors to see how they are doing?
$0.00
0.00% Upside
-
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| LLY Stock Forecast | Eli Lilly and | Outperform |
16
|
$787.02 | Buy/Sell | $636.99 | 11.50% |
| JNJ Stock Forecast | Johnson & Johnson | Outperform |
9
|
$152.67 | Buy/Sell | $174.55 | 11.35% |
| MRK Stock Forecast | Merck | Outperform |
2
|
$131.73 | Buy/Sell | $130.51 | 8.56% |
| PFE Stock Forecast | Pfizer | Outperform |
2
|
$28.82 | Buy/Sell | $32.87 | 5.83% |
| VRTX Stock Forecast | Vertex Pharmaceuticals Inc | Outperform |
12
|
$437.49 | Buy/Sell | $457.59 | 4.51% |
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| REGN Stock Forecast | Regeneron Pharmaceuticals | Outperform |
2
|
$978.21 | Buy/Sell | $961.26 | 7.34% |
| BMY Stock Forecast | Bristol-Myers Squibb | Hold |
2
|
$44.55 | Buy/Sell | $58.15 | 21.21% |
| ZTS Stock Forecast | Zoetis | Outperform |
18
|
$173.28 | Buy/Sell | $220.47 | 26.96% |
.jpg)
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| ALNY Stock Forecast | Alnylam Pharmaceuticals Inc | Outperform |
7
|
$147.40 | Buy/Sell | $245.24 | 47.56% |
| BAX Stock Forecast | Baxter International Inc | Hold |
17
|
$35.43 | Buy/Sell | $44.86 | 24.19% |
| VTRS Stock Forecast | Viatris Inc | Hold |
8
|
$11.07 | Buy/Sell | $11.73 | 8.40% |
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| UTHR Stock Forecast | United Therapeutics | Outperform |
12
|
$272.69 | Buy/Sell | $284.08 | 10.02% |
| CTLT Stock Forecast | Catalent | Hold |
15
|
$55.61 | Buy/Sell | $49.29 | 14.19% |
| CYTK Stock Forecast | Cytokinetics | Outperform |
10
|
$60.50 | Buy/Sell | $87.92 | 55.37% |
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| IONS Stock Forecast | Ionis Pharmaceuticals | Outperform |
9
|
$39.21 | Buy/Sell | $55.60 | 53.02% |
| BCPC Stock Forecast | Balchem | Outperform |
18
|
$156.36 | Buy/Sell | $145.00 | 5.53% |
| MDGL Stock Forecast | Madrigal Pharmaceuticals | Outperform |
4
|
$211.73 | Buy/Sell | $315.92 | 82.31% |
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| PRGO Stock Forecast | Perrigo Co PLC | Outperform |
16
|
$30.22 | Buy/Sell | $44.75 | 32.36% |
| NEOG Stock Forecast | Neogen | Outperform |
16
|
$13.30 | Buy/Sell | $37.00 | 27.82% |
| CORT Stock Forecast | Corcept Therapeutics | Buy |
16
|
$27.83 | Buy/Sell | $35.67 | 43.73% |
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| INDV Stock Forecast | Indivior PLC | Buy |
14
|
£13.85 | Buy/Sell | £28.89 | 123.32% |
| TGTX Stock Forecast | TG Therapeutics | Outperform |
9
|
$17.72 | Buy/Sell | $29.44 | 94.70% |
| AMPH Stock Forecast | Amphastar Pharmaceuticals | Outperform |
14
|
$42.44 | Buy/Sell | $69.00 | 46.09% |
.jpg)